Seeking Alpha13h
Organon: Certainly A Risky Bet, But Looks Increasingly Compelling (Upgrade)
In this update, I'll focus on Organon's Q3 2024 results, earnings adjustments and segment performance, as well as the ...
ETF Daily News17h
CWA Asset Management Group LLC Makes New $355,000 Investment in Organon & Co. (NYSE:OGN)
CWA Asset Management Group LLC acquired a new position in Organon & Co. (NYSE:OGN – Free Report) in the third quarter, ...
FiercePharma11h
BMS, Merck, Amgen and more must look to M&A to offset looming patent lapses: Leerink
As a wave of patent expirations encroaches upon many of the world’s top drugmakers, companies will need to be diligent in ...
Cellebrite: A Reasonable Valuation Given The Huge Cross-Sell Runway
Cellebrite has a significant opportunity to expand its business beyond digital forensics. Click here for our investment ...
The New York Times12h
New York Times - Top Stories
At Mar-a-Lago, ‘Uncle’ Elon Musk Puts His Imprint on the Trump Transition He’s on the patio. He’s on the golf course. Everywhere President-elect Trump looks, there is the world’s richest ...